Get the Stockscreener App
52.68
0.13%
0.07
After Hours:
52.70
0.02
+0.04%
Terns Pharmaceuticals Inc stock is traded at $52.68, with a volume of 4.68M.
It is up +0.13% in the last 24 hours and up +13.24% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of chronic disease. The company's oncology asset is TERN-701, a novel, oral allosteric BCR-ABL1 inhibitor for CML currently in Phase 1/2 development. The company's legacy metabolic programs include TERN-501, a clinical-stage thyroid hormone receptor-Beta for MASH and/or obesity, and TERN-801, a glucose-dependent insulinotropic polypeptide receptor antagonist development candidate for obesity. The company is seeking strategic partners to advance the TERN-501 and TERN-801 programs.
See More
Previous Close:
$52.61
Open:
$52.67
24h Volume:
4.68M
Relative Volume:
0.91
Market Cap:
$6.08B
Revenue:
-
Net Income/Loss:
$-96.21M
P/E Ratio:
-51.02
EPS:
-1.0326
Net Cash Flow:
$-82.18M
1W Performance:
+0.11%
1M Performance:
+13.24%
6M Performance:
+551.98%
1Y Performance:
+2,181%
1-Day Range:
$52.60
$52.69
1-Week Range:
$52.55
$52.75
52-Week Range:
$2.215
$53.19
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
52.68 | 6.07B | 0 | -96.21M | -82.18M | -1.0326 |
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-09-26 | Initiated | Leerink Partners | Outperform |
| Nov-04-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Nov-03-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Oct-15-25 | Initiated | Truist | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-04-25 | Resumed | H.C. Wainwright | Neutral |
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
Wall Street Recap: Is Terns Pharmaceuticals Inc a top pick in the sector2026 Trading Volume Trends & Weekly Stock Performance Updates - baoquankhu1.vn
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
TERN PE Ratio & Valuation, Is TERN Overvalued - Intellectia AI
TERN SEC FilingsTerns Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti Investigates Proposed Sale - National Today
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc.TERN - ChartMill
Merck’s Lower Terns Bid Highlights Oncology Ambition And Valuation Questions - Sahm
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? - Finviz
Merck nears $6 billion deal to buy Terns Pharma: Report - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasda - ChartMill
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition - CHEManager.
Merck begins tender offer to buy Terns Pharmaceuticals - MSN
TERN Stock Price, Quote & Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Merck & Co Inc Stock (MRK) Moved Up by 3.18% on Apr 8: Facts Behind the Movement - TradingKey
$680 Million in Daily Turnover Crowns Terns as Most Active Stock Ahead of Merck Deal - Bitget
How Merck slashed its bid for Terns Pharmaceuticals by $1B after reviewing cancer drug trial data - The Business Journals
Why Terns Pharmaceuticals Stock Rocked the Market in March - The Globe and Mail
Mizuho reiterates Terns Pharmaceuticals stock rating at Neutral By Investing.com - Investing.com Canada
Terns’ drug may not be as competitive as many initially thought - statnews.com
Leerink Partners Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating - Moomoo
Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals - Indian Pharma Post
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review - Sahm
Merck’s US$6.7b Terns Deal And What It Means For Valuation - Sahm
Merck’s (NYSE:MRK) Terns Deal And S&P 500 Valuation Impact Explained - Kalkine Media
William Blair Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Announces Target Price $53 - Moomoo
William Blair downgrades Terns Pharmaceuticals stock rating on Merck deal By Investing.com - Investing.com Canada
Merck To Acquire Terns Pharmaceuticals - citybiz
What's Going On With Merck Stock Tuesday? - Benzinga
Terns rebuffed a higher bid before selling to Merck - BioPharma Dive
Merck (MRK) Initiates Tender Offer for Terns Pharmaceuticals - GuruFocus
Merck begins tender offer to buy Terns Pharmaceuticals (MRK:NYSE) - Seeking Alpha
Merck begins tender offer to acquire Terns Pharmaceuticals, Inc. - marketscreener.com
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share - StreetInsider
Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc. - TradingView
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Bluefield Daily Telegraph
[SC 14D9] Terns Pharmaceuticals, Inc. Tender Offer Recommendation - Stock Titan
Merck (NYSE: TERN) to acquire Terns for $53.00 per share cash - Stock Titan
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a ... - Bluefield Daily Telegraph
Shareholder Alert: Ademi LLP investigates whether Terns - GlobeNewswire
Merck nears deal to buy Terns Pharmaceuticals - MSN
Merck to buy Terns for $6.7 billion to grow in blood cancers - MSN
43,857 Shares in Terns Pharmaceuticals, Inc. $TERN Acquired by SG Americas Securities LLC - MarketBeat
Capricorn Fund Managers Ltd Takes $6.12 Million Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
TERN Technical Analysis | Trend, Signals & Chart Patterns | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Aug Mood: Can Terns Pharmaceuticals Inc be the next market leaderGap Up & Real-Time Stock Entry Alerts - baoquankhu1.vn
Barclays downgrades Terns Pharmaceuticals (TERN) - MSN
Terns Pharmaceuticals Grants Inducement Shares to New Employees - National Today
Emil Kuriakose Sells 942 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat
Terns Pharmaceuticals (TERN) CMO sells shares to cover RSU taxes - Stock Titan
Press Release: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - Moomoo
Merck's $6.7 billion Terns Pharmaceuticals acquisition may face rival interest: Analyst - MSN
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):